Oncology Today with Dr Neil Love

By Research To Practice

Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.

  1. 1.
    Renal Cell Carcinoma with Dr Sumanta Pal
    42:45
  2. 2.
    Thyroid Cancer with Dr Marcia Brose
    43:56
  3. 3.
    Gastroesophageal Cancers with Dr Samuel Klempner
    1:08:51
  4. 4.
    Management of HER2-Low Breast Cancer with Dr Ian Krop
    43:26
  5. 5.
    Key Presentations on Gynecologic Cancers from the 2021 ASCO Annual Meeting with Dr Kathleen Moore
    47:52
  6. 6.
    Thyroid Cancer with Dr Lori Wirth
    51:33
  7. 7.
    Key Presentations on Lung Cancer from the 2021 ASCO Annual Meeting with Dr Joel Neal
    56:22
  8. 8.
    CAR T-Cell Therapy in Multiple Myeloma with Dr Jesús Berdeja
    48:38
  1. 9.
    Key Presentations on Gastrointestinal Cancers from the 2021 ASCO Annual Meeting with Dr Kristen Ciombor
    44:35
  2. 10.
    Key Presentations on Breast Cancer from the 2021 ASCO Annual Meeting with Dr Sara Tolaney  
    56:23
  3. 11.
    Gastroesophageal Cancers with Dr Jaffer Ajani
    41:28
  4. 12.
    Key Presentations on Genitourinary Cancers from the 2021 ASCO Annual Meeting with Dr Arjun Balar
    51:27
  5. 13.
    Progress in Myelodysplastic Syndromes with Dr Guillermo Garcia-Manero
    44:50
  6. 14.
    HER2-Positive Localized Breast Cancer with Dr Adam Brufsky
    43:47
  7. 15.
    Genomic Assays in Early Breast Cancer
    1:06:51
  8. 16.
    Advances in the Management of Amyloid Light Chain Amyloidosis with Dr Morie Gertz
    57:12
  9. 17.
    Advances in the Management of Cholangiocarcinoma with Dr Mitesh Borad
    40:12
  10. 18.
    Management of Localized Non-Small Cell Lung Cancer with EGFR Tumor Mutations with Dr Roy Herbst
    39:06
  11. 19.
    Key Presentations on Non-Hodgkin and Hodgkin Lymphomas from the 2020 ASH Annual Meeting with Dr Laurie Sehn
    1:02:42
  12. 20.
    Key Presentations on Multiple Myeloma, Waldenström Macroglobulinemia and Amyloidosis from the 2020 ASH Annual Meeting with Dr Natalie Callander
    1:03:50
  13. 21.
    Side Effects of Hormonal Therapy in Prostate Cancer with Dr Roberto Iacovelli
    47:43
  14. 22.
    Key Presentations on Acute Myeloid Leukemia and Myelodysplastic Syndromes from the 2020 ASH Annual Meeting with Dr Harry Erba
    1:06:21
  15. 23.
    Management of CNS Metastases in Patients with Non-Small Cell Lung Cancer with Dr Manmeet Ahluwalia
    1:05:02
  16. 24.
    Novel and Emerging Strategies for Diffuse Large B-Cell Lymphoma with Dr Gilles Salles
    1:12:30
  17. 25.
    Management of Acute Myeloid Leukemia Not Eligible for Intensive Induction Therapy with Dr Andrew Wei
    54:15
  18. 26.
    PARP Inhibitors in Ovarian Cancer with Dr Antonio González-Martín
    44:47
  19. 27.
    Predictors of Response to Cancer Immunotherapy with Prof Solange Peters
    1:11:48
  20. 28.
    Recently Approved Agents in Multiple Myeloma with Dr Joseph Mikhael
    45:59
  21. 29.
    Current and Emerging Strategies for Patients with Non-Small Cell Lung Cancer Harboring an EGFR Exon 20 Insertion Mutation with Dr Zofia Piotrowska
    1:05:29
  22. 30.
    Newly Approved Agents in HER2-Positive Metastatic Breast Cancer with Dr Mark Pegram
    1:05:14
  23. 31.
    Current Role of Minimal Residual Disease Assessment in the Management of Multiple Myeloma and Chronic Lymphocytic Leukemia with Drs Shaji Kumar and Philip Thompson
    1:17:12
  24. 32.
    New Targets in Non-Small Cell Lung Cancer with Dr Justin Gainor
    45:48
  25. 33.
    ER-Positive Metastatic Breast Cancer with Dr Erika Hamilton
    43:15
  26. 34.
    Key Presentations on Chronic Lymphocytic Leukemia and Follicular Lymphoma from the 2020 ASH Annual Meeting with Dr Ann LaCasce
    1:00:58
  27. 35.
    Current and Future Treatment Strategies for Advanced Ovarian Cancer with Dr Kathleen Moore 
    1:06:30
  28. 36.
    Front-Line Treatment of Chronic Lymphocytic Leukemia with Dr Steven Coutre
    1:17:34
  29. 37.
    Key Presentations on Myeloproliferative Neoplasms from the 2020 ASH Annual Meeting with Dr Aaron T Gerds
    1:10:54
  30. 38.
    Newly Approved Agents in the Management of Urothelial Bladder Carcinoma with Dr Matthew Galsky
    40:23
  31. 39.
    Role of Immune Checkpoint Inhibitors in the Management of Metastatic NSCLC without Actionable Mutations with Dr Corey Langer
    39:04
  32. 40.
    The Evolving Role of PARP Inhibition in the Management of Ovarian Cancer with Dr Shannon Westin
    1:05:56
  33. 41.
    Key Presentations on the Treatment of Multiple Myeloma from the 2020 ASH Annual Meeting with Dr Sagar Lonial
    1:04:12
  34. 42.
    Current Challenges of COVID-19 in Southern California with Dr David Quinn
    11:16
  35. 43.
    Current Management of and Future Directions in Mesothelioma with Dr Marjorie Zauderer
    43:08
  36. 44.
    The Role of Immunotherapy Combination Approaches in the Management of Metastatic Non-Small Cell Lung Cancer with Dr Stephen Liu
    50:04
  37. 45.
    The Role of PARP Inhibition in the Management of Breast Cancer with Dr Hope Rugo
    43:52
  38. 46.
    The Role of PARP Inhibition in the Management of Ovarian Cancer with Dr Ursula Matulonis
    36:19
  39. 47.
    The Role of PARP Inhibition in the Management of Pancreatic Cancer with Dr Philip A Philip
    36:44
  40. 48.
    The Role of PARP Inhibition in the Management of Prostate Cancer with Dr Maha Hussain
    40:15
  41. 49.
    Immune Checkpoint Inhibitors in Urothelial Bladder Carcinoma with Dr Joaquim Bellmunt
    42:18
  42. 50.
    Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in the Management of Gynecologic Cancers with Dr David O'Malley
    45:38

Listen to Oncology Today with Dr Neil Love now.

Listen to Oncology Today with Dr Neil Love in full in the Spotify app